The FDA has fully approved Komzifti (ziftomenib), the first and only once-daily oral menin inhibitor, for adults with R/R NPM1-mutated AML. empr.com/news/komzifti-…

🎧 Listen to the latest MPR Weekly Dose Podcast for a 12-minute breakdown of the week's top drug news including: 💊 Boxed Warnings to be removed from HRT labels; 😞 Caplyta approved for MDD; 🔹 Trial investigates simplified HIV regimen. ➡️ empr.com/news/mpr-weekl…

October 2025 Drug Approvals: Our at-a-glance essential prescribing update. empr.com/news/october-2…

Tonmya (cyclobenzaprine HCl sublingual tablets) is now commercially available, the first new FDA-approved fibromyalgia treatment in over 15 years. #Fibromyalgia #DrugApprovals #NewDrug empr.com/news/fibromyal…

Thrombate III becomes only antithrombin concentrate approved in both adults and pediatrics for hereditary antithrombin deficiency. ➡️ ➡️empr.com/news/thrombate…

Agios' mitapivat did lead to a reduction in sickle cell disease pain crises but the reduction was not statistically significant compared to placebo. ➡️ empr.com/news/mixed-res…

Leading medical organizations have strongly opposed recent CDC updates suggesting a link between vaccines and autism. ➡️ empr.com/news/medical-s…

🎧 Stay informed with MPR's breakdown of the week's top drug news in 14 minutes: 🔹 FDA Safety Alert on Elevidys; 🔸 Fibromyalgia treatment now available; 🔹 Plus: new FCS approval & SCD trial results for mitapivat. ➡️ empr.com/news/mpr-weekl… #DrugApprovals #DMD #Fibromyalgia

Keytruda indication expanded to include muscle invasive bladder cancer patients who are ineligible for cisplatin-containing chemotherapy. ➡️ empr.com/news/fda-appro…

The relative efficacy of the modRNA vaccine was 34.5% against influenza-like illness compared with the control vaccine. #immunization #vaccines empr.com/news/modified-…

Asundexian significantly reduced the risk of recurrent stroke vs placebo when added to antiplatelet therapy. ➡️ empr.com/news/asundexia…

Regulatory Watch: FDA initiates investigation into Adzynma following fatality. ➡️ empr.com/news/patient-d…

The GERD treatment will be back on shelves following its removal in 2020 due to unacceptable levels of NDMA. ➡️ empr.com/news/fda-clear…

New treatment gains accelerated approval to reduce proteinuria in adults with primary IgAN at risk for disease progression. #DrugApprovals ➡️ empr.com/news/voyxact-a…

Happy Thanksgiving to all our readers! 🍽️ 🍂

The approval of the autoinjector would drastically reduce the time it takes for patients to administer Furoscix. empr.com/news/mannkinds…

Ralph Abraham is the new principal deputy director at the CDC. In the past he has supported the use of unproven COVID treatments such as hydroxychloroquine and ivermectin, and has urged people to avoid Tylenol during pregnancy. ➡️ empr.com/news/cdc-names…

The memo did not include important details such as the children’s ages or how the FDA reached its conclusions about the vaccine’s role in the deaths. ➡️ empr.com/news/fda-memo-…

New trial data released for deramiocel in Duchenne muscular dystrophy; earlier this year the FDA issued a Complete Response Letter for the treatment. empr.com/news/deramioce…

CDC votes to end Hep B birth vaccine; the American Academy of Pediatrics issued a statement calling the new guidance “irresponsible” and “purposely misleading.” ➡️ empr.com/news/acip-vote…